You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

microgynon®

Showing 1 - 8 of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial (BI 456906, Microgynon®)

Not yet recruiting
  • Healthy
  • BI 456906
  • Microgynon®
  • (no location specified)
Jun 14, 2023

Relapsing Multiple Sclerosis (RMS) Trial in Germany, Poland (Cladribine, Placebo, Microgynon®)

Active, not recruiting
  • Relapsing Multiple Sclerosis (RMS)
  • Bochum, Germany
  • +6 more
Feb 8, 2022

Healthy Trial in Mannheim (Microgynon®, BI 425809)

Recruiting
  • Healthy
  • Microgynon®
  • BI 425809
  • Mannheim, Germany
    CRS Clinical Research Services Mannheim GmbH
Jan 30, 2023

Diabetes, Type 2 Trial in Berlin (Semaglutide 1.34 mg/mL, Semaglutide 3.0 mg/mL, NNC0480-0389 10 mg/mL)

Recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide 1.34 mg/mL
  • +4 more
  • Berlin, Germany
    Novo Nordisk Investigational Site
Jan 3, 2022

Diabetes, Diabetes, Type 2 Trial in Berlin (semaglutide, SNAC, Microgynon®)

Completed
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Berlin, Germany
    Novo Nordisk Investigational Site
Jun 6, 2017

Healthy Volunteer Trial in Manchester (Aleglitazar, Microgynon®, Placebo)

Completed
  • Healthy Volunteer
  • Manchester, United Kingdom
    (unnamed)
Nov 1, 2016

Healthy Trial in Mannheim (faldaprevir, Microgynon®, BI 207127)

Terminated
Has Results
  • Healthy
  • Mannheim, Germany
    1241.31.2 Boehringer Ingelheim Investigational Site
Mar 16, 2016

Healthy Trial (Microgynon®, BI 1356)

Completed
  • Healthy
  • Microgynon®
  • BI 1356
  • (no location specified)
Jul 4, 2014